Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Cardiovasc Pharmacol Ther ; 29: 10742484241256271, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39053441

RESUMEN

AIMS: In patients with atrial fibrillation (AF) and stroke risk factors, randomized trials have demonstrated that anticoagulation decreases the risk of ischemic stroke. However, all trials to date have excluded patients with significant liver disease, leaving guidelines to extrapolate recommendations. We aim to evaluate the impact of anticoagulation on safety events in patients with AF and cirrhosis. METHODS AND RESULTS: In this retrospective cohort study, we obtained de-identified health record data to extract anticoagulation strategy, comorbidities, prescriptions, lab values, and procedures for a cohort of patients with cirrhosis who develop AF. After selecting a propensity matched population to match patients with various anticoagulation strategies, we tracked data on outcomes for death, transfusion requirements, hospital and ICU admissions. After propensity score weighting and multivariable adjustment, anticoagulation strategy was associated with increased hospital admission count (OR = 1.74 per admission, P < .001), binary risk of hospital admission (OR = 1.54, P = .010) and risk of ICU admission (OR = 1.41, P = .047). We detected no significant differences in mortality, transfusion of blood products, or average length of stay. Direct oral anticoagulant (DOAC) prescriptions were associated with increased binary risk of hospital admission compared to warfarin prescriptions. In a third comparison, DOAC strategy alone was associated with increased hospital admission count (OR = 1.41 per admission, P < .001) and binary risk of hospital admission (OR = 1.52, P = .038) compared to no anticoagulation strategy. CONCLUSION: Anticoagulation strategy in patients with cirrhosis and AF was associated with increased rate of hospital admission and ICU admission but not associated with increased risk of mortality or transfusion requirement.


Asunto(s)
Anticoagulantes , Fibrilación Atrial , Cirrosis Hepática , Humanos , Fibrilación Atrial/tratamiento farmacológico , Fibrilación Atrial/complicaciones , Fibrilación Atrial/mortalidad , Fibrilación Atrial/diagnóstico , Masculino , Estudios Retrospectivos , Femenino , Cirrosis Hepática/complicaciones , Cirrosis Hepática/mortalidad , Anciano , Persona de Mediana Edad , Anticoagulantes/efectos adversos , Anticoagulantes/uso terapéutico , Anticoagulantes/administración & dosificación , Factores de Riesgo , Resultado del Tratamiento , Transfusión Sanguínea , Medición de Riesgo , Warfarina/efectos adversos , Warfarina/uso terapéutico , Factores de Tiempo , Hemorragia/inducido químicamente , Admisión del Paciente , Accidente Cerebrovascular/prevención & control , Accidente Cerebrovascular/mortalidad , Accidente Cerebrovascular/epidemiología
2.
HGG Adv ; 5(3): 100302, 2024 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-38704641

RESUMEN

Polygenic scores (PGSs) summarize the combined effect of common risk variants and are associated with breast cancer risk in patients without identifiable monogenic risk factors. One of the most well-validated PGSs in breast cancer to date is PGS313, which was developed from a Northern European biobank but has shown attenuated performance in non-European ancestries. We further investigate the generalizability of the PGS313 for American women of European (EA), African (AFR), Asian (EAA), and Latinx (HL) ancestry within one institution with a singular electronic health record (EHR) system, genotyping platform, and quality control process. We found that the PGS313 achieved overlapping areas under the receiver operator characteristic (ROC) curve (AUCs) in females of HL (AUC = 0.68, 95% confidence interval [CI] = 0.65-0.71) and EA ancestry (AUC = 0.70, 95% CI = 0.69-0.71) but lower AUCs for the AFR and EAA populations (AFR: AUC = 0.61, 95% CI = 0.56-0.65; EAA: AUC = 0.64, 95% CI = 0.60-0.680). While PGS313 is associated with hormone-receptor-positive (HR+) disease in EA Americans (odds ratio [OR] = 1.42, 95% CI = 1.16-1.64), this association is lost in African, Latinx, and Asian Americans. In summary, we found that PGS313 was significantly associated with breast cancer but with attenuated accuracy in women of AFR and EAA descent within a singular health system in Los Angeles. Our work further highlights the need for additional validation in diverse cohorts prior to the clinical implementation of PGSs.


Asunto(s)
Bancos de Muestras Biológicas , Neoplasias de la Mama , Predisposición Genética a la Enfermedad , Humanos , Neoplasias de la Mama/genética , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/etnología , Femenino , Los Angeles/epidemiología , Persona de Mediana Edad , Factores de Riesgo , Herencia Multifactorial , Curva ROC , Adulto , Anciano , Polimorfismo de Nucleótido Simple
3.
J Neurooncol ; 157(3): 499-510, 2022 May.
Artículo en Inglés | MEDLINE | ID: mdl-35384518

RESUMEN

PURPOSE: We sought to characterize clinical outcomes for adult and pediatric patients with primary CNS tumors harboring DICER1 mutations or loss of DICER1. METHODS: We conducted a retrospective cohort study of 98 patients who were treated between 1995 and 2020 for primary CNS tumors containing DICER1 mutations or loss of DICER1 on chromosome 14q, identified by targeted next generation sequencing. Kaplan-Meier plots and log rank tests were used to analyze survival. Cox proportional-hazards model was used for univariate and multivariable analyses for all-cause mortality (ACM). RESULTS: Within our cohort, the most common malignancies were grade 3/4 glioma (61%), grade 1/2 glioma (17%), and CNS sarcoma (6%). Sarcoma and non-glioma histologies, and tumors with biallelic DICER1 mutations or deletions were common in the pediatric population. Mutations occurred throughout DICER1, including missense mutations in the DexD/H-box helicase, DUF283, RNaseIIIa, and RNaseIIIb domains. For patients with grade 3/4 glioma, MGMT methylation (Hazard ratio [HR] 0.35, 95% Confidence Interval [CI] 0.16-0.73, p = 0.005), IDH1 R132 mutation (HR 0.11, 95% CI 0.03-0.41, p = 0.001), and missense mutation in the DexD/H-box helicase domain (HR 0.06, 95% CI 0.01-0.38, p = 0.003) were independently associated with longer time to ACM on multivariable analyses. CONCLUSION: DICER1 mutations or loss of DICER1 occur in diverse primary CNS tumors, including previously unrecognized grade 3/4 gliomas as the most common histology. While prior studies have described RNaseIIIb hotspot mutations, we document novel mutations in additional DICER1 functional domains. Within the grade 3/4 glioma cohort, missense mutation in the DexD/H-box helicase domain was associated with prolonged survival.


Asunto(s)
Neoplasias del Sistema Nervioso Central , Glioma , Sarcoma , Adulto , Neoplasias del Sistema Nervioso Central/genética , Niño , ARN Helicasas DEAD-box/genética , Glioma/patología , Humanos , Mutación , Pronóstico , Estudios Retrospectivos , Ribonucleasa III/genética , Sarcoma/patología
4.
Entropy (Basel) ; 24(10)2022 Oct 09.
Artículo en Inglés | MEDLINE | ID: mdl-37420459

RESUMEN

Dimethyl carbonate is an important green chemical that has been widely used in the chemical industry. In the production of dimethyl carbonate, methanol oxidative carbonylation has been studied, but the conversion ratio of dimethyl carbonate using this method is too low, and the subsequent separation requires a large amount of energy due to methanol and dimethyl carbonate being azeotrope. In this paper, the strategy of "reaction instead of separation" is proposed. Based on this strategy, a novel process is developed to combine the production of DMC with that of dimethoxymethane (DMM) and dimethyl ether (DME). The co-production process was simulated using Aspen Plus software, and the product purity was up to 99.9%. The exergy analysis of the co-production process and the existing process was carried out. The exergy destruction and exergy efficiency were compared with those of the existing production processes. The results show that the exergy destruction of the co-production process is about 276% less than that of the single-production processes, and the exergy efficiencies in the developed co-production process are significantly improved. The utility loads of the co-production process are significantly lower than that of the single-production process. The developed co-production process increases the methanol conversion ratio to 95%, with a reduced energy requirement. It is proved that the developed co-production process can provide an advantageous option over the existing processes with improved energy efficiency and material savings. The strategy of "reaction instead of separation" is feasible. A new strategy is proposed for azeotrope separation.

5.
Clin Nutr ; 41(12): 3069-3076, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-33934924

RESUMEN

BACKGROUND & AIMS: Early reports suggest significant difficulty with enteral feeding in critically ill COVID-19 patients. This study aimed to characterize the prevalence, clinical manifestations, and outcomes of feeding intolerance in critically ill patients with COVID-19. METHODS: We examined 323 adult patients with COVID-19 admitted to the intensive care units (ICUs) of Massachusetts General Hospital between March 11 and June 28, 2020 who received enteral nutrition. Systematic chart review determined prevalence, clinical characteristics, and hospital outcomes (ICU complications, length of stay, and mortality) of feeding intolerance. RESULTS: Feeding intolerance developed in 56% of the patients and most commonly manifested as large gastric residual volumes (83.9%), abdominal distension (67.2%), and vomiting (63.9%). Length of intubation (OR 1.05, 95% CI 1.03-1.08), ≥1 GI symptom on presentation (OR 0.76, 95% CI 0.59-0.97), and severe obesity (OR 0.29, 95% CI 0.13-0.66) were independently associated with development of feeding intolerance. Compared to feed-tolerant patients, patients with incident feeding intolerance were significantly more likely to suffer cardiac, renal, hepatic, and hematologic complications during their hospitalization. Feeding intolerance was similarly associated with poor outcomes including longer ICU stay (median [IQR] 21.5 [14-30] vs. 15 [9-22] days, P < 0.001), overall hospitalization time (median [IQR] 30.5 [19-42] vs. 24 [15-35], P < 0.001) and in-hospital mortality (33.9% vs. 16.1%, P < 0.001). Feeding intolerance was independently associated with an increased risk of death (HR 3.32; 95% CI 1.97-5.6). CONCLUSIONS: Feeding intolerance is a frequently encountered complication in critically ill COVID-19 patients in a large tertiary care experience and is associated with poor outcomes.


Asunto(s)
COVID-19 , Enfermedad Crítica , Adulto , Humanos , Recién Nacido , Enfermedad Crítica/terapia , COVID-19/complicaciones , COVID-19/epidemiología , COVID-19/terapia , Unidades de Cuidados Intensivos , Nutrición Enteral/efectos adversos , Mortalidad Hospitalaria
6.
Int J Biol Macromol ; 172: 10-18, 2021 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-33388320

RESUMEN

Wastewater contaminated with dyes is discharged by huge amount daily, and involved many hazardous materials. Thus, this study focused on introducing low cost, ecofriendly and available removal agent (lignin-based adsorbent). Three adsorbents, APKL-4, APKL-5 and APKL-6 were obtained using gradient acid precipitation technology and used for methylene blue (MB) removal. The samples were characterized by SEM, FT-IR and zeta potential analyzer. The results indicated that the three adsorbents exhibit significantly different adsorption behavior due to the structural differences caused by fractionation. The APKL-5 and APKL-6 have fewer hydrophilic groups in their molecules and thus have more adsorption active sites to load MB molecules. A pore structure inside of APKL-5 molecules is form in acid fractionation, which allows it to carry more MB molecules. The adsorption capacity of APKL-5 increased 3.8 times (from 345 to 1310 mg g-1) in the alkaline solution which showing excellent pH responsiveness. This paper presents a new promising approach for preparing high efficiency, low cost and eco-friendly adsorbents and builds a foundation for developing further applications of lignin-based adsorbents.


Asunto(s)
Ácidos/química , Fraccionamiento Químico/métodos , Colorantes/química , Lignina/química , Adsorción , Cinética , Azul de Metileno/química , Espectroscopía Infrarroja por Transformada de Fourier/métodos , Aguas Residuales/química , Contaminantes Químicos del Agua/química , Purificación del Agua/métodos
7.
Phys Rev E ; 95(6-1): 063309, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28709266

RESUMEN

Flow and heat transfer in periodic structures are of great interest for many applications. In this paper, we carefully examine the periodic features of fully developed periodic incompressible thermal flows, and incorporate them in the lattice Boltzmann method (LBM) for flow and heat transfer simulations. Two numerical approaches, the distribution modification (DM) approach and the source term (ST) approach, are proposed; and they can both be used for periodic thermal flows with constant wall temperature (CWT) and surface heat flux boundary conditions. However, the DM approach might be more efficient, especially for CWT systems since the ST approach requires calculations of the streamwise temperature gradient at all lattice nodes. Several example simulations are conducted, including flows through flat and wavy channels and flows through a square array with circular cylinders. Results are compared to analytical solutions, previous studies, and our own LBM calculations using different simulation techniques (i.e., the one-module simulation vs. the two-module simulation, and the DM approach vs. the ST approach) with good agreement. These simple, however, representative simulations demonstrate the accuracy and usefulness of our proposed LBM methods for future thermal periodic flow simulations.

8.
J Biol Chem ; 292(27): 11547-11560, 2017 07 07.
Artículo en Inglés | MEDLINE | ID: mdl-28526747

RESUMEN

The peroxins Pex19 and Pex3 play an indispensable role in peroxisomal membrane protein (PMP) biogenesis, peroxisome division, and inheritance. Pex19 plays multiple roles in these processes, but how these functions relate to the structural organization of the Pex19 domains is unresolved. To this end, using deletion mutants, we mapped the Pex19 regions required for peroxisome biogenesis in the yeast Pichia pastoris Surprisingly, import-competent peroxisomes still formed when Pex19 domains previously believed to be required for biogenesis were deleted, although the peroxisome size was larger than that in wild-type cells. Moreover, these mutants exhibited a delay of 14-24 h in peroxisome biogenesis. The shortest functional N-terminal (NTCs) and C-terminal constructs (CTCs) were Pex19 (aa 1-150) and Pex19 (aa 89-300), respectively. Deletions of the N-terminal Pex3-binding site disrupted the direct interactions of Pex19 with Pex3, but preserved interactions with a membrane peroxisomal targeting signal (mPTS)-containing PMP, Pex10. In contrast, deletion of the C-terminal mPTS-binding domain of Pex19 disrupted its interaction with Pex10 while leaving the Pex19-Pex3 interactions intact. However, Pex11 and Pex25 retained their interactions with both N- and C-terminal deletion mutants. NTC-CTC co-expression improved growth and reversed the larger-than-normal peroxisome size observed with the single deletions. Pex25 was critical for peroxisome formation with the CTC variants, and its overexpression enhanced their interactions with Pex3 and aided the growth of both NTC and CTC Pex19 variants. In conclusion, physical segregation of the Pex3- and PMP-binding domains of Pex19 has provided novel insights into the modular architecture of Pex19. We define the minimum region of Pex19 required for peroxisome biogenesis and a unique role for Pex25 in this process.


Asunto(s)
Proteínas Fúngicas , Membranas Intracelulares , Proteínas de la Membrana , Peroxisomas , Pichia , Secuencia de Aminoácidos , Sitios de Unión , Proteínas Fúngicas/química , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Membranas Intracelulares/química , Membranas Intracelulares/metabolismo , Proteínas de la Membrana/química , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Peroxisomas/química , Peroxisomas/genética , Peroxisomas/metabolismo , Pichia/química , Pichia/genética , Pichia/metabolismo , Eliminación de Secuencia
9.
Bioresour Technol ; 192: 432-40, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26072276

RESUMEN

This work investigated a top-lit open microalgae bioreactor that uses a gas-lift system to enable deeper production depths, thereby significantly reducing the footprint. Growth of Scenedesmus sp. in a one-meter deep system by sparged with 6% CO2-enhanced air was evaluated. The results gave comparable volumetric biomass productivity (0.06 g(dw) L(-1) day(-1)), but around three-times higher areal productivity (60.0 g(dw)m(-)(2) day(-)(1)) than reported for traditional raceways. The lipid content of the Scenedesmus sp. was increased by 27% with an enhanced level of CO2 in the sparging gas.


Asunto(s)
Reactores Biológicos , Biotecnología/instrumentación , Microalgas/crecimiento & desarrollo , Scenedesmus/crecimiento & desarrollo , Biotecnología/métodos , Dióxido de Carbono/metabolismo , Secuestro de Carbono , Eficiencia , Diseño de Equipo , Luz , Metabolismo de los Lípidos , Lípidos/análisis , Microalgas/metabolismo , Scenedesmus/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA